By: Sophie Shulman
Duvakitug signals a brighter future for the Israeli pharma giant.
Sophie Shulman is a tech journalist who writes for CTech by Calcalist and Ynet News. With a focus on the Israeli tech scene, Sophie covers topics such as private equity investment, cybersecurity, high-tech partnerships, and the impact of global politics on the tech industry. She provides in-depth analysis and insights into the latest trends and developments in the Israeli tech ecosystem.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sophie's coverage predominantly focuses on the Israeli tech sector, investments, IPOs, and cybersecurity. She is particularly interested in articles that cite data and press releases, indicating that she values factual evidence and official announcements.
Given her interest in investment analysis and private sector announcements related to technology companies, Sophie may be open to receiving pitches from industry experts who can provide insights into market trends or offer exclusive data relevant to the Israeli tech industry.
Additionally, considering her focus on government & politics alongside business & industry topics with a specific emphasis on Israel's high-tech sector, she might appreciate commentary from individuals knowledgeable about governmental policies impacting the tech industry or those with expertise in navigating the intersection of business and politics within this sector.
This information evolves through artificial intelligence and human feedback. Improve this profile .